Skip to main content

and
  1. Article

    Open Access

    Clinical significance of CD151 overexpression in subtypes of invasive breast cancer

    CD151 is a member of the tetraspanin family, which interacts with laminin-binding integrins and other tetraspanins. This protein is implicated in motility, invasion, and metastasis of cancer cells, but the pre...

    M J Kwon, S Park, J Y Choi, E Oh, Y J Kim, Y-H Park, E Y Cho in British Journal of Cancer (2012)

  2. Article

    Open Access

    Thymidine synthase, thymidine phosphorylase, and excision repair cross-complementation group 1 expression as predictive markers of capecitabine plus cisplatin chemotherapy as first-line treatment for patients with advanced oesophageal squamous cell carcinoma

    Our purpose was to evaluate thymidine synthase (TS), thymidine phosphorylase (TP), and excision repair cross-complementation group 1 (ERCC1) expression as biomarkers for capecitabine and cisplatin (XP) combina...

    S Lee, Y H Park, K H Kim, E Y Cho, Y C Ahn, K Kim, Y-M Shim in British Journal of Cancer (2010)

  3. No Access

    Article

    Evaluation of ER and Ki-67 proliferation index as prognostic factors for survival following neoadjuvant chemotherapy with doxorubicin/docetaxel for locally advanced breast cancer

    The aim of the study was to identify reliable predictive biological markers for treatment outcome following neoadjuvant adriamycin/docetaxel (AT) chemotherapy in locally advanced breast cancer patients.

    J. Lee, Y. H. Im, S. H. Lee, E. Y. Cho, Y. L. Choi in Cancer Chemotherapy and Pharmacology (2008)